MARKET CREATORGlobal Wellness Industry Intelligence

Global Wellness Industry Intelligence

CONNECTING WELLNESS
한국어English中文日本語
News

Encora X1 opens a VA ordering route

Source publication date

Site published

The new milestone is procurement access. X1 applies mechanical stimulation to peripheral nerve distributions at the wrist; it is not electrical muscle stimulation.

FDA record K251517 dates its 510(k) clearance to February 5, 2026. The indication is assistance with hand-tremor relief in the treated limb during stimulation in adults with essential tremor.

Summary

On October 15, Encora announced that VA facilities can order its prescription X1 wrist wearable through Lovell Government Services.

Editorial view

Editorial view: an existing cleared device has gained a defined public-healthcare purchasing route. Actual prescriptions, orders and deliveries remain separate milestones.

Evidence and limitations

This is not a new FDA clearance. Availability does not establish universal eligibility, automatic coverage, delivery volumes or a cure.

Sources

Encora Therapeutics

FDA

FDA

Encora Therapeutics